Table 2.
Friedman test results for the difference between the clinical and functional scoring results over time.
V0 (n = 10) | V1 (n = 10) | V2 (n = 10) | V3 (n = 10) | V4 (n = 10) | V5 (n = 10) | P | |
---|---|---|---|---|---|---|---|
VAS | 6.7 ± 2.24 | 7.0 ± 1.9 | 5.8 ± 3.8 | 4.7 ± 3.5 | 3.6 ± 2.8* | 3.4 ± 3.3* | .000 |
WOMAC | 49.7 ± 19.4 | 49.8 ± 28.1 | 45.8 ± 32.8 | 40.0 ± 29.7 | 34.5 ± 24.6* | 27.0 ± 22.9* | .007 |
Leqeusne | 12.8 ± 3.56 | 14.9 ± 5.1 | 11.9 ± 7.2 | 12.4 ± 6.8 | 10, ± 6.7 | 11.1 ± 7.01 | .239 |
SF-36 | 42.4 ± 20.6 | 44.0 ± 22.3 | 45.6 ± 28.3 | 56.4 ± 29.6 | 61.8 ± 26.6* | 61.1 ± 29.9* | .032 |
SF-36 = 36-Item Short Form Health Survey, VAS = visual analog scale, WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index.
P < 0.05 to values that are significantly different from the initial (V0) values.